{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:24:58Z","timestamp":1760549098756,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.clon.2011.04.012","type":"journal-article","created":{"date-parts":[[2011,5,26]],"date-time":"2011-05-26T16:16:23Z","timestamp":1306426583000},"page":"572-578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Primary Excision Margins and Sentinel Lymph Node Biopsy in Clinically Node-negative Melanoma of the Trunk or Extremities"],"prefix":"10.1016","volume":"23","author":[{"given":"F.","family":"Wright","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Spithoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Easson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Toye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"McCready","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Petrella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2010","series-title":"Canadian cancer statistics 2010","key":"10.1016\/j.clon.2011.04.012_bib1"},{"key":"10.1016\/j.clon.2011.04.012_bib2","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1200\/JCO.1995.13.2.502","article-title":"The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation","volume":"13","author":"Browman","year":"1995","journal-title":"J Clin Oncol"},{"year":"2003","series-title":"Cutaneous melanoma: a national clinical guideline","key":"10.1016\/j.clon.2011.04.012_bib3"},{"year":"2006","series-title":"Improving outcomes for people with skin tumours including melanoma: the manual","key":"10.1016\/j.clon.2011.04.012_bib4"},{"year":"2007","series-title":"Evidence-based clinical\u00a0practice guideline: treatment of cutaneous melanoma","key":"10.1016\/j.clon.2011.04.012_bib5"},{"year":"2008","series-title":"Clinical practice guidelines for the management of melanoma in Australia and New Zealand","key":"10.1016\/j.clon.2011.04.012_bib6"},{"key":"10.1016\/j.clon.2011.04.012_bib7","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/archsurg.142.9.885","article-title":"Excision margins for primary cutaneous melanoma. Updated pooled analysis of randomized controlled trials","volume":"142","author":"Lens","year":"2007","journal-title":"Arch Surg"},{"issue":"4","key":"10.1016\/j.clon.2011.04.012_bib8","article-title":"Surgical excision margins for primary cutaneous melanoma","author":"Sladden","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clon.2011.04.012_bib9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1245\/s10434-009-0780-2","article-title":"Sentinel lymph node dissection in primary melanoma reduces subsequent regional lymph node metastasis as well as distant metastasis after nodal involvement","volume":"17","author":"Leiter","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clon.2011.04.012_bib10","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/archsurg.137.10.1101","article-title":"Excision margins in the treatment of primary cutaneous melanoma: a systematic review of randomized controlled trials comparing narrow vs wide excision","volume":"137","author":"Lens","year":"2002","journal-title":"Arch Surg"},{"key":"10.1016\/j.clon.2011.04.012_bib11","first-page":"419","article-title":"Optimal excision margins for primary cutaneous melanoma: a systematic review and meta-analysis","volume":"46","author":"Haigh","year":"2003","journal-title":"Can J Surg"},{"key":"10.1016\/j.clon.2011.04.012_bib12","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1001\/archsurg.1991.01410280036004","article-title":"Narrow excision (1-cm margin). A safe procedure for thin cutaneous melanoma","volume":"126","author":"Veronesi","year":"1991","journal-title":"Arch Surg"},{"key":"10.1016\/j.clon.2011.04.012_bib13","first-page":"101","article-title":"Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1\u20134 mm melanomas","volume":"8","author":"Balch","year":"2001","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clon.2011.04.012_bib14","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/1097-0142(20001001)89:7<1495::AID-CNCR12>3.0.CO;2-D","article-title":"Long term results of a randomized study by the Swedish Melanoma Study Group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8\u20132.0 mm","volume":"89","author":"Cohn-Cedermark","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2011.04.012_bib15","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/cncr.11272","article-title":"Surgical margins in cutaneous melanoma (2 cm versus 5 cm for lesions measuring less than 2.1-mm thick)","volume":"97","author":"Khayat","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2011.04.012_bib16","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1056\/NEJMoa030681","article-title":"Excision margins in high-risk malignant melanoma","volume":"350","author":"Thomas","year":"2004","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.clon.2011.04.012_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004835","article-title":"Surgical excision margins for localised cutaneous melanoma [intervention protocol]","author":"Sladden","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clon.2011.04.012_bib18","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/jso.21282","article-title":"Standardized synoptic cancer pathology reporting: a population-based approach","volume":"99","author":"Srigley","year":"2009","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.clon.2011.04.012_bib19","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.surg.2009.09.032","article-title":"Improvement in the accuracy of reporting key prognostic and anatomic findings during thyroidectomy by using a novel web-based synoptic operative reporting system","volume":"146","author":"Chambers","year":"2009","journal-title":"Surgery"},{"key":"10.1016\/j.clon.2011.04.012_bib20","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1365-2559.2007.02921.x","article-title":"The advantage of using a synoptic pathology report format for cutaneous melanoma","volume":"52","author":"Karim","year":"2008","journal-title":"Histopathology"},{"key":"10.1016\/j.clon.2011.04.012_bib21","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1200\/JCO.2001.19.16.3622","article-title":"Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system","volume":"19","author":"Balch","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2011.04.012_bib22","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMoa060992","article-title":"Sentinel-node biopsy or nodal observation in melanoma","volume":"355","author":"Morton","year":"2006","journal-title":"N Eng J Med"},{"key":"10.1016\/j.clon.2011.04.012_bib23","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1200\/JCO.2009.27.1627","article-title":"Multivariate analysis of prognostic factors among 2313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases","volume":"28","author":"Balch","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2011.04.012_bib24","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2011.04.012_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S1470-2045(05)70518-0","article-title":"Time for comprehensive reporting of MSLT-1","volume":"7","author":"Thomas","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clon.2011.04.012_bib26","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1056\/NEJMc062965","article-title":"Sentinel-node biopsy in melanoma","volume":"356","author":"Grichnik","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clon.2011.04.012_bib27","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/ncponc0791","article-title":"Is sentinel-node biopsy superior to nodal observation in melanoma?: commentary","volume":"4","author":"Gershenwald","year":"2007","journal-title":"Natl Clin Pract Oncol"},{"key":"10.1016\/j.clon.2011.04.012_bib28","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/archderm.143.6.775","article-title":"Cloud of sentinel node biopsy: unlikely survival benefit in melanoma","volume":"143","author":"Gonzalez","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clon.2011.04.012_bib29","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/archsurg.1989.01410090061014","article-title":"Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases","volume":"124","author":"Calabro","year":"1989","journal-title":"Arch Surg"},{"issue":"18S","key":"10.1016\/j.clon.2011.04.012_bib30","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2009.27.18_suppl.lba9084","article-title":"Adjuvant radiotherapy and regional lymph node field control in melanoma patients after lymphadenectomy: results of an intergroup randomized trial (ANZMTG 01.01\/TROG 02.01)","volume":"27","author":"Henderson","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2011.04.012_bib31","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archsurg.1992.01420040034005","article-title":"Technical details of intraoperative lymphatic mapping for early stage melanoma","volume":"127","author":"Morton","year":"1992","journal-title":"Arch Surg"},{"key":"10.1016\/j.clon.2011.04.012_bib32","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1046\/j.1365-2168.2000.01362.x","article-title":"Reliability of sentinel lymph node biopsy for staging melanoma","volume":"87","author":"Jansen","year":"2000","journal-title":"Br J Surg"},{"key":"10.1016\/j.clon.2011.04.012_bib33","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1245\/ASO.2003.01.023","article-title":"Review and evaluation of sentinel node procedures in 250 melanoma patients with a median follow-up of 6 years","volume":"10","author":"Estourgie","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clon.2011.04.012_bib34","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/01.sla.0000181092.50141.fa","article-title":"Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-1, an international multicenter trial","volume":"242","author":"Morton","year":"2005","journal-title":"Ann Surg"},{"key":"10.1016\/j.clon.2011.04.012_bib35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/CMR.0b013e3282f2017d","article-title":"Postoperative morbidity of lymph node excision for cutaneous melanoma-sentinel lymphonodectomy versus complete regional lymph node dissection","volume":"18","author":"Kretschmer","year":"2008","journal-title":"Melanoma Res"},{"key":"10.1016\/j.clon.2011.04.012_bib36","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.ejso.2007.07.197","article-title":"Prognostic value of sentinel node biopsy in 327 prospective melanoma patients from a single institution","volume":"34","author":"Roulin","year":"2008","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clon.2011.04.012_bib37","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/jso.20084","article-title":"Lessons learned from the Sunbelt melanoma trial","volume":"86","author":"McMasters","year":"2004","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.clon.2011.04.012_bib38","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/cncr.24044","article-title":"Meta-analysis of sentinel lymph node positivity in thin melanoma (\u22641 mm)","volume":"115","author":"Warycha","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2011.04.012_bib39","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1200\/JCO.2001.19.9.2370","article-title":"High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH\/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of Intergroup trial E1694\/S9512\/C509801","volume":"19","author":"Kirkwood","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2011.04.012_bib40","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(08)61033-8","article-title":"Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial","volume":"372","author":"Eggermont","year":"2008","journal-title":"Lancet"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655511006753?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655511006753?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:37:17Z","timestamp":1760542637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655511006753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0936655511006753"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2011.04.012","relation":{},"ISSN":["0936-6555"],"issn-type":[{"type":"print","value":"0936-6555"}],"subject":[],"published":{"date-parts":[[2011,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary Excision Margins and Sentinel Lymph Node Biopsy in Clinically Node-negative Melanoma of the Trunk or Extremities","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2011.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}